Re the Expo as it was a pain conference with academics (not investors) in which it was pitching the Epat app at, I believe this will take some time to bear fruit
- e.g academics (from nurses, pain management physicians, hospitals,Dr's etc who were all in attendance) going back to there respective businesses explaining the benefits of the app.
Hopefully over the coming months we will see the benefits of attending the Expo as well as the Bupa multi site test already announced.
I do agree with the Roadshow commentary and PR as investors look for these items to make informed buying decisions.
Keep up the good work
EPT Price at posting:
2.8¢ Sentiment: Buy Disclosure: Held
(20min delay)